Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Belloli

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
ERJ Open Research|December 3, 2024
Acute exacerbations in patients with progressive pulmonary fibrosisMichael Kreuter, Elizabeth A Belloli, Elisabeth Bendstrup, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 4, 2020
Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survivalMichael P Combs, Meng Xia, David S Wheeler, et al.
American Journal of Respiratory and Critical Care Medicine|July 28, 2021
Radiographic Graft Surveillance in Lung Transplantation: Prognostic Role of Parametric Response MappingElizabeth A Belloli, Tian Gu, Yizhuo Wang, et al.
The Journal of Biological Chemistry|January 13, 2016
Mechanistic Target of Rapamycin Complex 1 (mTORC1) and mTORC2 as Key Signaling Intermediates in Mesenchymal Cell ActivationNatalie M Walker, Elizabeth A Belloli, Linda Stuckey, et al.
Respiratory Medicine|March 5, 2019
Frailty and geriatric conditions in older patients with idiopathic pulmonary fibrosisJamie S Sheth, Meng Xia, Susan Murray, et al.
American Journal of Respiratory and Critical Care Medicine|October 26, 2016
Parametric Response Mapping as an Imaging Biomarker in Lung Transplant RecipientsElizabeth A Belloli, Irina Degtiar, Xin Wang, et al.
JAMA|May 19, 2024
Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical TrialGanesh Raghu, Luca Richeldi, Evans R Fernández Pérez, et al.
The European Respiratory Journal|July 2, 2021
Effects of nintedanib by inclusion criteria for progression of interstitial lung diseaseToby M Maher, Kevin K Brown, Michael Kreuter, et al.
Chest|September 24, 2018
Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function TrajectoryMargaret L Salisbury, Tian Gu, Susan Murray, et al.
The European Respiratory Journal|June 28, 2018
Development and validation of a radiological diagnosis model for hypersensitivity pneumonitisMargaret L Salisbury, Barry H Gross, Aamer Chughtai, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
ERJ Open Research|December 3, 2024
Acute exacerbations in patients with progressive pulmonary fibrosisMichael Kreuter, Elizabeth A Belloli, Elisabeth Bendstrup, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 4, 2020
Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survivalMichael P Combs, Meng Xia, David S Wheeler, et al.
American Journal of Respiratory and Critical Care Medicine|July 28, 2021
Radiographic Graft Surveillance in Lung Transplantation: Prognostic Role of Parametric Response MappingElizabeth A Belloli, Tian Gu, Yizhuo Wang, et al.
The Journal of Biological Chemistry|January 13, 2016
Mechanistic Target of Rapamycin Complex 1 (mTORC1) and mTORC2 as Key Signaling Intermediates in Mesenchymal Cell ActivationNatalie M Walker, Elizabeth A Belloli, Linda Stuckey, et al.
Respiratory Medicine|March 5, 2019
Frailty and geriatric conditions in older patients with idiopathic pulmonary fibrosisJamie S Sheth, Meng Xia, Susan Murray, et al.
American Journal of Respiratory and Critical Care Medicine|October 26, 2016
Parametric Response Mapping as an Imaging Biomarker in Lung Transplant RecipientsElizabeth A Belloli, Irina Degtiar, Xin Wang, et al.
JAMA|May 19, 2024
Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical TrialGanesh Raghu, Luca Richeldi, Evans R Fernández Pérez, et al.
The European Respiratory Journal|July 2, 2021
Effects of nintedanib by inclusion criteria for progression of interstitial lung diseaseToby M Maher, Kevin K Brown, Michael Kreuter, et al.
Chest|September 24, 2018
Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function TrajectoryMargaret L Salisbury, Tian Gu, Susan Murray, et al.
The European Respiratory Journal|June 28, 2018
Development and validation of a radiological diagnosis model for hypersensitivity pneumonitisMargaret L Salisbury, Barry H Gross, Aamer Chughtai, et al.
Pageof 3